Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Granules India

BSE: 532482|NSE: GRANULES|ISIN: INE101D01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 17, 16:00
91.10
3.05 (3.46%)
VOLUME 313,778
LIVE
NSE
Jul 17, 15:59
91.10
2.8 (3.17%)
VOLUME 5,278,537
Announcements on Granules India

16th-Jul-2018 16:03Source: NSE

Granules India Limited

Granules India Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

16th-Jul-2018 09:26Source: BSE

Granules India- Board Meeting To Be Held On 23Rd July 2018 (Payment of First Interim Dividend)

Board Meeting to be held on 23rd July 2018

16th-Jul-2018 09:26Source: BSE

Granules India- Board Meeting To Be Held On 23Rd July 2018

Board Meeting to be held on 23rd July 2018

5th-Jul-2018 10:29Source: BSE

Granules India- Shareholding for the Period Ended June 30, 2018

Granules India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly

21st-Jun-2018 11:26Source: NSE

Granules India Limited

Granules India Limited has informed the Exchange regarding allotment of 255000 securities pursuant to ESOP/ESPS at its meeting held on Jun 21, 2018

21st-Jun-2018 11:09Source: BSE

Granules India- Announcement under Regulation 30 (LODR)-Allotment

Allotment of 2,55,000 equity shares under ESOS

1st-Jun-2018 08:53Source: NSE

Granules India Limited

Granules India Limited has informed the Exchange regarding 'Receipt of Establishment Inspection Report (EIR) US FDA - Reg.'.

1st-Jun-2018 08:53Source: BSE

Granules India- Receipt Of Establishment Inspection Report (EIR) US FDA -Reg

Receipt of Establishment Inspection Report (EIR) US FDA -Reg

30th-May-2018 17:37Source: BSE

Granules India- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for IDBI Trusteeship Services Ltd

30th-May-2018 16:29Source: BSE

Granules India- Announcement under Regulation 30 (LODR)-Press Release / Media Release

Granules Pharmaceuticals, Inc., the wholly owned subsidiary of Granules India Ltd., launched generic Methylergonovine tablets in partnership with Hikma.

1 2 3 4 5 Next >>
Quick Links for Granules India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.